Northwest Biotherapeutics NWBO

OTC: NWBO | ISIN: US66737P6007   2/07/2025
0,246 USD (+3,49%)
(+3,49%)   2/07/2025
Grafiek Northwest Biotherapeutics Grafiek Northwest Biotherapeutics

Northwest Biotherapeutics in het nieuws

3 juli 2024 · Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities · Persbericht

17 juni 2024 · Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property · Persbericht

21 maart 2024 · Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors · Persbericht

6 februari 2024 · Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification · Persbericht

21 december 2023 · Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma · Persbericht

13 oktober 2023 · Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application · Persbericht

12 september 2023 · Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board · Persbericht

29 augustus 2023 · Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application · Persbericht

21 maart 2023 · Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility · Persbericht

12 maart 2023 · Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB · Persbericht

Mijn selecties